Trial Details
COMPLETEDBasic Information
| Clinical ID | c1217 |
|---|---|
| Identifier | NCT05389709 |
| Trial Title | A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Functional Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia|Irritable Bowel Syndrome|Functional Dyspepsia |
| Interventions | DRUG: Iberogast (STW5-II, BAY98-7410) |
Participant Information
| Sponsor | Bayer |
|---|---|
| City | Many Locations |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2022-06-04 |
|---|---|
| Primary Completion Date | 2023-05-11 |
| Completion Date | 2023-05-11 |